Dowden Nathan J

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
25
Insider Sells Sum
$1.78M

Insider Activity of Dowden Nathan J

According to the SEC Form 4 filings, Dowden Nathan J, being in a position of

  1. President & COO at Entrada Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 32073 shares for $511,605,
    over all time since 2022-06-27, has bought 0 shares, and sold 109746 shares for $1.78M.

The largest sale of all time was on 2024-08-16 and amounted to 27097 shares of Entrada Therapeutics, Inc. for $440,801.

Biography of Dowden Nathan J

No biography is available at this moment.

2024-09-26SaleEntrada Therapeutics, Inc.
TRDA
President & COO
847
0.0025%
$16.00$13,5520%
2024-09-09SaleEntrada Therapeutics, Inc.
TRDA
President & COO
1,904
0.0051%
$15.07$28,690-0.2%
2024-09-06SaleEntrada Therapeutics, Inc.
TRDA
President & COO
399
0.0011%
$15.19$6,063+1.35%
2024-08-16SaleEntrada Therapeutics, Inc.
TRDA
President & COO
27,097
0.0841%
$16.27$440,8010%
2024-03-06SaleEntrada Therapeutics, Inc.
TRDA
President & COO
1,826
0.0055%
$12.32$22,499+18.48%
2023-09-06SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
972
0.0028%
$13.47$13,089+5.66%
2023-07-11SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
3,897
0.0121%
$18.05$70,333-18.27%
2023-07-10SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
3,200
0.0099%
$18.00$57,605-18.13%
2023-06-22SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
7,097
0.022%
$16.02$113,700-7.79%
2023-06-20SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
8,885
0.0273%
$14.94$132,704-1.73%
2022-10-31SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
2,100
0.0071%
$24.05$50,495-34.88%
2022-10-25SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
9,348
0.0299%
$20.77$194,191-28.33%
2022-10-24SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
2,404
0.0075%
$19.30$46,402-24.39%
2022-10-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
2,771
0.0086%
$18.29$50,668-21.22%
2022-10-20SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
905
0.0029%
$18.07$16,357-18.1%
2022-10-20SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
1,810
0.0057%
$18.07$32,713-18.1%
2022-09-26SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
3,088
0.0103%
$15.45$47,707+0.51%
2022-09-23SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
1,018
0.0032%
$15.07$15,341-1.33%
2022-09-23SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
2,036
0.0065%
$15.07$30,681-1.33%
2022-09-21SaleEntrada Therapeutics, Inc.
TRDA
Chief Operating Officer
3,275
0.0113%
$15.13$49,537+6.47%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.